CF
CHRS icon

CNA Financial’s Coherus Oncology CHRS Stock Holding History

CNA Financial’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,451
Closed -$273K – 92
2022
Q3 		$273K Sell
28,451
-510
-2% -$5.16K 0.1% 146
2022
Q2 		$210K Sell
28,961
-230
-0.8% -$2K 0.07% 166
2022
Q1 		$377K Sell
29,191
-110
-0.4% -$1.4K 0.12% 163
2021
Q4 		$468K Buy
29,301
+3,140
+12% +$54.9K 0.12% 164
2021
Q3 		$420K Buy
26,161
+1,080
+4% +$15.8K 0.11% 171
2021
Q2 		$347K Buy
25,081
+140
+0.6% +$1.98K 0.1% 183
2021
Q1 		$364K Sell
24,941
-3,199
-11% -$54.3K 0.11% 180
2020
Q4 		$489K Buy
28,140
+3,250
+13% +$57.9K 0.15% 160
2020
Q3 		$456K Buy
24,890
+2,810
+13% +$52.3K 0.17% 139
2020
Q2 		$394K Buy
+22,080
New +$374K 0.16% 150

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CNA Financial's CHRS Position: Q4 2022 in Review

CNA Financial sold out of Coherus Oncology (CHRS) in Q4 2022, closing a stake of 28,451 shares — an estimated $273K sold.

CNA Financial first reported a position in CHRS in Q2 2020 and held it in 10 quarters. The position peaked at $489K in Q4 2020. 161 funds tracked by Wall St. Rank hold CHRS as of Q4 2022.

  • CNA Financial reported no remaining Coherus Oncology position as of Q4 2022 after selling out during the quarter.
  • CNA Financial sold 28,451 Coherus Oncology shares in Q4 2022, an estimated $273K.
  • CNA Financial first reported a position in Coherus Oncology in Q2 2020 and held it in 10 quarters.
  • CNA Financial's Coherus Oncology position peaked at $489K in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2022.

Based on CNA Financial's 13F filing for Q4 2022, filed 10 Feb 2023.